Theranostics · 2024 · 22 citations · 0 references
MedicineCancer BiologyOncologyCancer GeneticsGene ExpressionMolecular OncologyCancer MetabolismHepatocellular CarcinomaLipid MetabolismLiver CancerMetabolic ReprogrammingMetabolic Reprogramming In CancerHepatic Iron RegulationHepatocellular Carcinoma PathogenesisSorafenib Therapy
Our results indicated the pivotal role of lipid metabolism-related and liver-specific HNF4A-AS1 in inhibiting sorafenib resistance by promoting ferroptosis and suggesting that HNF4A-AS1 might be a potential target for HCC.